EMD SERONO, INC. for EMD SERONO INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 22, 2024 | $780,000 | Replaced |
| 1st Quarter - Amendment | May 23, 2024 | $780,000 | Yes |
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 547: Better Care Better Jobs Act; all provisions of the bill H.R. 830: Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill H.R. 2534: Preserving Rules Ordered for The Entities Covered Through 340B Act of 2023(PROTECT 340B Act); all provisions of the bill H.R. 2880: Protecting Patients Against PBM Abuses Act; all provisions of the bill H.R. 5378: Lower Costs, More Transparency Act; all provisions of the bill H.R. 7635: The 340B PATIENTS Act of 2024; all provisions of the bill S. 100: Better Care Better Jobs Act; all provisions of the bill S. 1339: Pharmacy Benefit Manager Reform Act; all provisions of the bill S. 1375: Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill S. 1542: Delinking Revenue from Unfair Gouging (DRUG) Act; all provisions of the bill S. 1967: Patients Before Middlemen (PBM) Act; all provisions of the bill P.L. 117-169: Inflation Reduction Act of 2022; implementation of Drug pricing provisions General discussions related to 340B Drug Pricing Program policy issues General discussions related to Pharmacy Benefit Manager policy issues General discussions related to Healthcare supply chain policy issues General discussions related to Drug cost and pricing policy issues General discussions related to caregiving support and awareness policy issues General discussions related to the Cancer Moonshot Initiative and the Advanced Research Projects Agency for Health (ARPA-H)
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Medicare/Medicaid MMM
H.R. 2880: Protecting Patients Against PBM Abuses Act; all provisions of the bill H.R. 5378: Lower Costs, More Transparency Act; all provisions of the bill H.R. 7635: The 340B PATIENTS Act of 2024; all provisions of the bill S. 1967: Patients Before Middlemen (PBM) Act; all provisions of the bill P.L. 117-169: Inflation Reduction Act of 2022; implementation of Parts B & D provisions General discussions related to Drug cost and pricing policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Pharmacy PHA
H.R. 830: Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill H.R. 5378: Lower Costs, More Transparency Act; all provisions of the bill H.R. 7635: The 340B PATIENTS Act of 2024; all provisions of the bill S. 1339: Pharmacy Benefit Manager Reform Act; all provisions of the bill S. 1375: Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill S. 1542: Delinking Revenue from Unfair Gouging (DRUG) Act; all provisions of the bill General discussions related to Drug cost and pricing policy issues General discussions related to Healthcare supply chain policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Taxation/Internal Revenue Code TAX
H.R. 2673: American Innovation and R&D Competitiveness Act of 2023; provisions related to Research & Development (R & D) Tax Amortization S. 866: American Innovation and Jobs Act; provisions related to Research & Development (R & D) Tax Amortization
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Science/Technology SCI
P.L. 117-167: Supreme Court Security Funding Act of 2022 (H.R. 4346 -CHIPS and Science Act of 2022): issues related to the Notice Of Funding Opportunities (NOFO) for Research & Development (R & D)
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Budget/Appropriations BUD
S.2127: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024; provisions related to Veteran infertility benefits P.L. 118-42 (H.R. 4366): Consolidated Appropriations Act, 2024; provisions related to Veteran infertility benefits in the the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Veterans VET
P.L. 118-42 (H.R. 4366): Consolidated Appropriations Act, 2024; provisions related to Veteran infertility benefits in the the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024 S.2127: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024; provisions related to Veteran infertility benefits General discussions regarding Veteran access to infertility care
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Trade (domestic/foreign) TRD
H.R. 3136: National Critical Capabilities Defense Act of 2023; provisions related to China and outbound investment review mechanism
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Environment/Superfund ENV
Discussions related to the Toxic Substances Control Act, PFAS, and the semiconductor industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Foreign Relations FOR
Discussions related to United States - China relations, and export controls
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Defense DEF
P.L. 118-31 (H.R. 2760): National Defense Authorization Act for Fiscal Year 2024; provisions related to the BIOSECURE Act S. 2226: National Defense Authorization Act for Fiscal Year 2024; provisions related to the BIOSECURE Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
Copyright/Patent/Trademark CPT
General discussions related to Biopharmaceutical innovation and patent policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.